We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05431270
Brief Title: Dose Escalation/Expansion Study of PT199 (an Anti-CD73 mAb) Administered Alone and in Combination With a PD-1 Inhibitor

First Submitted : May 25, 2022
First Submitted that Met QC Criteria : June 21, 2022
First Posted : June 24, 2022

Last Update Submitted that Met QC Criteria : November 30, 2022
Last Update Posted : December 2, 2022